Showing results (331-340 of 427) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2016
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527Rachel A Freedman, Jared C Foster, Drew K Seisler, et al.
The New England Journal of Medicine|September 3, 2004
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancerKevin S Hughes, Lauren A Schnaper, Donald Berry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancerMichael J Hassett, Samuel M Silver, Melissa E Hughes, et al.
Cancer Research|November 4, 2005
HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout miceLouise R Howe, Sung-Hee Chang, Kelly C Tolle, et al.
Clinical Breast Cancer|December 15, 2010
Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancerPamela Drullinsky, Steven M Sugarman, Monica N Fornier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2008
The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancerChau Dang, Monica Fornier, Steven Sugarman, et al.
Journal of the American Chemical Society|September 25, 2019
Antiferroelectric Phase Transition in a Proton-Transfer Salt of Squaric Acid and 2,3-DimethylpyrazineJeff Lengyel, Xiaoping Wang, Eun Sang Choi, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical OncologyA Recht, S B Edge, L J Solin, et al.
Clinical Breast Cancer|February 12, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancerKomal Jhaveri, Sarat Chandarlapaty, Diana Lake, et al.
Pageof 43